Immunoreactive β-Endorphin and Adrenocorticotropin in Human Cerebrospinal Fluid
Open Access
- 1 December 1980
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 66 (6) , 1383-1390
- https://doi.org/10.1172/jci109991
Abstract
To elucidate the significance of β-endorphin in human cerebrospinal fluid (CSF), CSF levels of β-endorphin-like immunoreactivity (β-EP-LI) in various diseases were determined by a specific radioimmunoassay and compared with simultaneously determined ACTH-like immunoreactivity (ACTH-LI) levels in CSF. CSF β-EP-LI and ACTH-LI in the control group, consisting of 5 normal subjects and 19 patients with nonendocrine diseases, were 22.2±1.3 and 14.6±0.4 fmol/ml, respectively. CSF levels of these peptides in patients with schizophrenia (n = 19) and acromegaly (n = 10) were not significantly different from those in the control group. Patients with Cushing's disease (n = 7) had significantly lower CSF β-EP-LI and ACTH-LI levels than those in the control group. Four of them showed a parallel increase in CSF β-EP-LI and CSF ACTH-LI levels after the complete removal of pituitary microadenomas (P < 0.05). Gel chromatography of CSF β-EP-LI from a normal volunteer, a control patient, and one patient each with catatonia, Nelson's syndrome, Cushing's syndrome (adrenal adenoma), and acromegaly gave similar patterns consisting of three peaks with the elution positions comparable to those of authentic β-endorphin, β-lipotropin, and possibly their precursor molecule. Gel chromatographic patterns of CSF β-EP-LI and ACTH-LI were compared in a normal volunteer. The first peaks of β-EP-LI and ACTH-LI eluted at the same position and the second peak of ACTH-LI coincided with the elution position of authentic ACTH. CSF β-EP-LI and ACTH-LI levels determined every 5 min over a period of 80 min in three normal volunteers did not show moment-to-moment variability. A significant correlation (r = 0.75, P < 0.001) was seen between CSF β-EP-LI and ACTH-LI levels in normal subjects and patients studied (n = 73). This suggests that β-endorphin and ACTH in human CSF share the common regulatory mechanism in normal and pathologic conditions.This publication has 40 references indexed in Scilit:
- Regional distribution of methionine-enkephalin- and beta-endorphin-like immunoreactivity in human brain and pituitaryBrain Research, 1979
- β-Endorphin in human plasma: Basal and pathologically elevated levelsLife Sciences, 1979
- Endorphins are stored in biologically active and inactive forms: isolation of α-N-acetyl peptidesNature, 1979
- Presence of immunoreactive β-endorphin in plasma of patients with Nelson's syndrome and Addison's diseaseLife Sciences, 1978
- Presence of immunoreactive β-lipotropin and β-endorphin in human placentaLife Sciences, 1978
- β-Endorphin Is Not Detectable in Plasma from Normal Human SubjectsScience, 1978
- $beta;-ENDORPHIN IN HUMAN CEREBROSPINAL FLUIDThe Lancet, 1978
- Radioimmunoassay for β-endorphin: Presence of immunoreactive “big-big” β-endorphin (“big” β-lipotropin) in human and rat pituitariesLife Sciences, 1978
- Cell‐free translation product containing corticotropin and β‐endorphin encoded by messenger RNA from anterior lobe and intermediate lobe of bovine pituitaryFEBS Letters, 1977
- Naloxone-induced reversal of schizophrenic hallucinationsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1977